within the fast evolving discipline of cancer therapeutics, comprehension the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is important for establishing powerful solutions. One of the most promising approaches is the usage of in vitro bystander outcome assays, which Participate in a pivotal purpose in maximizing therapeutic efficacy. The